skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
EPOCH Regimen (Code C63779)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: EPOCH Regimen

Definition: A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin) and doxorubicin hydrochloride (hydroxydaunorubicin hycrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B cell and T cell non-Hodgkin lymphomas.

Display Name: EPOCH Regimen

Label: EPOCH Regimen

NCI Thesaurus Code: C63779 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C3887850  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Dose-adjusted Etoposide/Vincristine/Doxorubicin/Cyclophosphamide/Prednisone Regimen
EPOCH Regimen
EPOCH regimen
Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin Regimen

External Source Codes: 
PDQ Closed Trial Search ID 38921
PDQ Open Trial Search ID 38921 (check for NCI PDQ open clinical trial info)
UMLS CUI C3887850

Other Properties:
     Name Value (qualifiers indented underneath)
code C63779
Contributing_Source CTRP
DesignNote Source: Physician's Cancer Chemotherapy Drug Manual 2006
Legacy_Concept_Name EPOCH_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom